Tech Company Financing Transactions
Affect Therapeutics Funding Round
Affect Therapeutics secured a $26 million Series B investment round on 11/5/2025. Backers included Providence Ventures and private investors.
Transaction Overview
Company Name
Announced On
11/5/2025
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series B
Investors
Providence Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
1640 Boro Place 4th Floor
McLean, VA 22102
USA
McLean, VA 22102
USA
Phone
Website
Email Address
Overview
Affect Therapeutics is a team of passionate people who are changing the way the world treats addiction. Drug overdose deaths have reached record levels in the US, with no signs of abating. And yet, the standard of care for substance use disorders is largely based on decades-old approaches with generally poor patient outcomes. By thoughtfully innovating with sound research, data, and well-proven engagement techniques, we can change all of that.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kristin Muhlner
Chief Technical Officer
Russell Osborne
Co-Founder
Rachel Lin
Browse more venture capital transactions:
Prev: 11/5/2025: FUTURE venture capital transaction
Next: 11/5/2025: Flux XII venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs